Article Text

Download PDFPDF
CASE REPORT
β-lactam-associated eosinophilic colitis
  1. Tamara Mogilevski1,
  2. David Nickless2,
  3. Sam Hume3
  1. 1Department of Medicine, The Northern Hospital, Epping, Victoria, Australia
  2. 2Department of Healthscope Pathology, The Northern Hospital, Melbourne, Victoria, Australia
  3. 3Department of Infectious Diseases, The Royal Melbourne Hospital, Melbourne, Victoria, Australia
  1. Correspondence to Dr Tamara Mogilevski, t.mogilevski{at}gmail.com

Summary

A 42-year-old man with a history of childhood asthma presented with a 2-week history of watery diarrhoea and marked peripheral eosinophilia in the setting of recent use of cephalexin. His colonoscopy revealed patchy colitis. Biopsies were consistent with eosinophilic colitis. Two months later he received a course of amoxicillin resulting in recurrence of peripheral eosinophilia. Given the time-frame of β-lactam administration to symptom onset and elimination of all other precipitating causes, he was diagnosed with β-lactam-associated eosinophilic colitis. The patient’s symptoms resolved and peripheral eosinophil count decreased with no specific treatment. Eosinophilic colitis is a rare heterogeneous condition, the pathogenesis of which is likely to be an interplay between environmental and genetic factors. It can be secondary to a helminthic infection or a drug reaction and has been associated with ulcerative colitis. If secondary causes of eosinophilic colitis have been excluded, the mainstay of treatment is with corticosteroids.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.